Stay updated on Acute Kidney Injury in Dapagliflozin vs Other Antidiabetics Clinical Trial

Sign up to get notified when there's something new on the Acute Kidney Injury in Dapagliflozin vs Other Antidiabetics Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Acute Kidney Injury in Dapagliflozin vs Other Antidiabetics Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Minor UI/layout adjustments and a timestamp update were made; core study details appear unchanged.
    Difference
    0.6%
    Check dated 2025-11-03T13:12:19.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    36 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).
    Difference
    5%
    Check dated 2025-10-06T04:15:11.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes provided.
    Difference
    0.1%
    Check dated 2025-09-28T23:35:11.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, updating the core version information. The 'Back to Top' item was removed as a minor UI change.
    Difference
    0.3%
    Check dated 2025-09-14T09:41:51.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a minor revision. There are no significant changes to core content or important information.
    Difference
    0.3%
    Check dated 2025-09-07T07:14:45.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location details, specifically identifying Washington D.C. as the location. Additionally, it now features a list of publications related to a safety study on Dapagliflozin, which enhances the core content of the page.
    Difference
    8%
    Check dated 2025-08-31T00:51:41.000Z thumbnail image

Stay in the know with updates to Acute Kidney Injury in Dapagliflozin vs Other Antidiabetics Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Acute Kidney Injury in Dapagliflozin vs Other Antidiabetics Clinical Trial page.